Endosomal escape pathways for delivery of biologicals

被引:1213
作者
Varkouhi, Amir K. [2 ]
Scholte, Marije [1 ]
Storm, Gert [2 ]
Haisma, Hidde J. [1 ]
机构
[1] Univ Groningen, Groningen Res Inst Pharm, NL-9713 AV Groningen, Netherlands
[2] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, Fac Sci, NL-3584 CA Utrecht, Netherlands
关键词
Endosomal escape; Cytosolic delivery; Protein; Gene; siRNA; CELL-PENETRATING PEPTIDES; STERIC-BLOCK OLIGONUCLEOTIDES; SENSITIVE FUSOGENIC PEPTIDE; NONVIRAL GENE DELIVERY; RICIN A-CHAIN; TRANSFECTION IN-VITRO; AERUGINOSA EXOTOXIN-A; BREAST-CANCER CELLS; HIV-1 TAT PROTEIN; MAMMALIAN-CELLS;
D O I
10.1016/j.jconrel.2010.11.004
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Despite continuous improvements in delivery systems, the development of methods for efficient and specific delivery of targeted therapeutic agents still remains an issue in biological treatments such as protein and gene therapy. The endocytic pathway is the major uptake mechanism of cells and any biological agents, such as DNA, siRNA and proteins. These agents become entrapped in endosomes and are degraded by specific enzymes in the lysosome. Thus, a limiting step in achieving an effective biological based therapy is to facilitate the endosomal escape and ensure cytosolic delivery of the therapeutics. Bacteria and viruses are pathogens which use different mechanisms to penetrate the membranes of their target cells and escape the endosomal pathway. Different mechanisms such as pore formation in the endosomal membrane, pH-buffering effect of protonable groups and fusion into the lipid bilayer of endosomes have been proposed to facilitate the endosomal escape. Several viral and bacterial proteins have been identified that are involved in this process. In addition, chemical agents and photochemical methods to rupture the endosomal membrane have been described. New synthetic biomimetic peptides and polymers with high efficacy in facilitating the endosomal escape, low pathogenicity and toxicity have been developed. Each strategy has different characteristics and challenges for designing the best agents and techniques to facilitate the endosomal escape are ongoing. In this review, several mechanisms and agents which are involved in endosomal escape are introduced. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:220 / 228
页数:9
相关论文
共 147 条
  • [1] Arginine-rich cell penetrating peptides: Design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides
    Abes, R.
    Arzumanov, A.
    Moulton, H.
    Abes, S.
    Ivanova, G.
    Gait, M. J.
    Iversen, P.
    Lebleu, B.
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (04) : 455 - 460
  • [2] Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide (vol 35, pg 4495, 2007)
    Abes, Said
    Turner, John J.
    Ivanova, Gabriela D.
    Owen, David
    Williams, Donna
    Arzumanov, Andrey
    Clair, Philippe
    Gait, Michael J.
    Lebleu, Bernard
    [J]. NUCLEIC ACIDS RESEARCH, 2007, 35 (21) : 7396 - 7396
  • [3] Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
    Al-Dosari, Mohammed S.
    Gao, Xiang
    [J]. AAPS JOURNAL, 2009, 11 (04): : 671 - 681
  • [4] Anderson WF, 1998, NATURE, V392, P25
  • [5] MEMBRANE TRANSLOCATION OF DIPHTHERIA TOXIN-A-FRAGMENT - ROLE OF CARBOXY-TERMINAL REGION
    ARIANSEN, S
    AFANASIEV, BN
    MOSKAUG, JO
    STENMARK, H
    MADSHUS, IH
    OLSNES, S
    [J]. BIOCHEMISTRY, 1993, 32 (01) : 83 - 90
  • [6] ANTIVIRAL STATE AGAINST INFLUENZA-VIRUS NEUTRALIZED BY MICROINJECTION OF ANTIBODIES TO INTERFERON-INDUCED MX PROTEINS
    ARNHEITER, H
    HALLER, O
    [J]. EMBO JOURNAL, 1988, 7 (05) : 1315 - 1320
  • [7] Asayama Shoichiro, 2004, Nucleic Acids Symp Ser (Oxf), P229
  • [8] Hybrid tetanus toxin C fragment-diphtheria toxin translocation domain allows specific gene transfer into PC12 cells
    Barati, S
    Chegini, F
    Hurtado, P
    Rush, RA
    [J]. EXPERIMENTAL NEUROLOGY, 2002, 177 (01) : 75 - 87
  • [9] Beerens A. M. J., 2003, Current Gene Therapy, V3, P486, DOI 10.2174/1566523034578258
  • [10] Berg K, 1999, CANCER RES, V59, P1180